Resultados da busca - Elvira Valera
- Mostrando 1 - 20 resultados de 20
-
1
Immunotherapy for neurodegenerative diseases: Focus on α-synucleinopathies por Elvira Valera, Eliezer Masliah
Publicado em 2013Revisão -
2
Combination therapies: The next logical Step for the treatment of synucleinopathies? por Elvira Valera, Eliezer Masliah
Publicado em 2015Revisão -
3
Therapeutic approaches in Parkinson's disease and related disorders por Elvira Valera, Eliezer Masliah
Publicado em 2016Revisão -
4
The neuropathology of multiple system atrophy and its therapeutic implications por Elvira Valera, Eliezer Masliah
Publicado em 2017Revisão -
5
-
6
-
7
-
8
-
9
-
10
A brain-targeted, modified neurosin (kallikrein-6) reduces α-synuclein accumulation in a mouse model of multiple system atrophy por Brian Spencer, Elvira Valera, Edward Rockenstein, Margarita Trejo-Morales, Anthony Adame, Eliezer Masliah
Publicado em 2015Artigo -
11
Combination of alpha-synuclein immunotherapy with anti-inflammatory treatment in a transgenic mouse model of multiple system atrophy por Elvira Valera, Brian Spencer, Jerel Adam Fields, Ivy Trinh, Anthony Adame, Michael Mante, Edward Rockenstein, Paula Desplats, Eliezer Masliah
Publicado em 2017Artigo -
12
<i>α</i>‐synuclein conformational antibodies fused to penetratin are effective in models of Lewy body disease por Brian Spencer, Stephanie Williams, Edward Rockenstein, Elvira Valera, Wei Xin, Michael Mante, Jazmin Florio, Anthony Adame, Eliezer Masliah, Michael R. Sierks
Publicado em 2016Artigo -
13
Reducing Endogenous α-Synuclein Mitigates the Degeneration of Selective Neuronal Populations in an Alzheimer's Disease Transgenic Mouse Model por Brian Spencer, Paula Desplats, Cassia Overk, Elvira Valera-Martin, Robert A. Rissman, Chengbiao Wu, Michael Mante, Anthony Adame, Jazmin Florio, Edward Rockenstein, Eliezer Masliah
Publicado em 2016Artigo -
14
MicroRNA-101 Modulates Autophagy and Oligodendroglial Alpha-Synuclein Accumulation in Multiple System Atrophy por Elvira Valera, Brian Spencer, Jennifer Mott, Margarita Trejo, Anthony Adame, Michael Mante, Edward Rockenstein, Juan C. Troncoso, Thomas G. Beach, Eliezer Masliah, Paula Desplats
Publicado em 2017Artigo -
15
Active immunization against alpha-synuclein ameliorates the degenerative pathology and prevents demyelination in a model of multiple system atrophy por Markus Mandler, Elvira Valera, Edward Rockenstein, Michael Mante, Harald Weninger, Christina Patrick, Anthony Adame, Sabine Schmidhuber, Radmila Santic, Achim Schneeberger, Walter Schmidt, Frank Mattner, Eliezer Masliah
Publicado em 2015Artigo -
16
Next-generation active immunization approach for synucleinopathies: implications for Parkinson’s disease clinical trials por Markus Mandler, Elvira Valera, Edward Rockenstein, Harald Weninger, Christina Patrick, Anthony Adame, Radmila Santic, Stefanie Meindl, Benjamin Vigl, Oskar W. Smrzka, Achim Schneeberger, Frank Mattner, Eliezer Masliah
Publicado em 2014Artigo -
17
Anti-α-synuclein immunotherapy reduces α-synuclein propagation in the axon and degeneration in a combined viral vector and transgenic model of synucleinopathy por Brian Spencer, Elvira Valera, Edward Rockenstein, Cassia Overk, Michael Mante, Anthony Adame, Wagner Zago, Peter Seubert, Robin Barbour, Dale Schenk, Dora Games, Robert A. Rissman, Eliezer Masliah
Publicado em 2017Artigo -
18
Reducing C-Terminal-Truncated Alpha-Synuclein by Immunotherapy Attenuates Neurodegeneration and Propagation in Parkinson's Disease-Like Models por Dora Games, Elvira Valera, Brian Spencer, Edward Rockenstein, Michael Mante, Anthony Adame, Christina Patrick, Kiren Ubhi, Silke Nuber, Patricia Sacayon, Wagner Zago, Peter Seubert, Robin Barbour, Dale Schenk, Eliezer Masliah
Publicado em 2014Artigo -
19
Exposure to bacterial endotoxin generates a distinct strain of α-synuclein fibril por Changyoun Kim, Guohua Lv, Jun Sung Lee, Byung Chul Jung, Masami Masuda‐Suzukake, Chul-Suk Hong, Elvira Valera, He-Jin Lee, Seung R. Paik, Masato Hasegawa, Eliezer Masliah, David Eliezer, Seung‐Jae Lee
Publicado em 2016Artigo -
20
α-Synuclein-induced myelination deficit defines a novel interventional target for multiple system atrophy por Benjamin Ettle, Bilal E. Kerman, Elvira Valera, Clarissa Gillmann, Johannes C. M. Schlachetzki, Simone Reiprich, Christian Büttner, Arif B. Ekici, André Reis, Michael Wegner, Tobias Bäuerle, Markus J. Riemenschneider, Eliezer Masliah, Fred H. Gage, Jürgen Winkler
Publicado em 2016Artigo
Ferramentas de busca:
Assuntos relacionados
Biology
Disease
Medicine
Neuroscience
Pathology
Parkinson's disease
Alpha-synuclein
Dementia
Dementia with Lewy bodies
Immunology
Biochemistry
Synucleinopathies
Atrophy
Cell biology
Gene
Neurodegeneration
Central nervous system
Immune system
Immunotherapy
Internal medicine
Genetically modified mouse
Neuroinflammation
Transgene
Alzheimer's disease
Antibody
Astrogliosis
Chemistry
Genetics
Inflammation
Neurology